Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Pediatr Res. 2021 Nov;90(5):1086-1092. doi: 10.1038/s41390-021-01484-9. Epub 2021 Apr 6.
Clinicians often express concerns about poor sensitivity of blood cultures in neonates resulting from inadequate inoculant volumes. Our objective was to determine the inoculant volume sent for neonatal sepsis evaluations and identify areas of improvement.
Single-center prospective observational study of infants undergoing sepsis evaluation. Blood volume was determined by clinician documentation over 21 months, and additionally by weighing culture bottles during 12 months. Adequate volume was defined as ≥1 mL total inoculant per evaluation. For first-time evaluations, local guidelines recommend sending an aerobic-anaerobic pair with 1 mL inoculant in each.
There were 987 evaluations in 788 infants. Clinicians reported ≥1 mL total inoculant in 96.9% evaluations. Among 544 evaluations where bottles were weighed, 93.4% had ≥1 mL total inoculant. Very low birth weight infants undergoing evaluations >7 days after birth had the highest proportion of inadequate inoculants (14.4%). Only 3/544 evaluations and 26/1011 bottles had total inoculant <0.5 mL. Ninety evaluations had <1 mL in both aerobic and anaerobic bottles despite a total inoculant volume that allowed inoculation of ≥1 mL in one of the bottles.
Obtaining recommended inoculant volumes is feasible in majority of neonates. Measuring inoculant volumes can focus improvement efforts and improve test reliability.
Clinicians express concern about the unreliability of neonatal blood cultures because of inadequate inoculant volume. We investigated over 900 evaluations and found >90% of evaluations have ≥1 mL inoculant. Monitoring adequacy of blood culture technique can identify areas of improvement and may allay concerns about blood culture reliability. Current recommendations for adequate inoculant volume for blood cultures are met in a majority of neonates. Areas of improvement include preterm late-onset sepsis evaluations and distribution techniques during inoculation.
临床医生常对新生儿血培养的敏感性较差表示担忧,这可能是由于接种量不足所致。我们的目的是确定用于新生儿脓毒症评估的接种量,并确定需要改进的领域。
对进行脓毒症评估的婴儿进行单中心前瞻性观察研究。通过临床医生在 21 个月内的记录来确定血容量,通过在 12 个月内称重培养瓶来确定血容量。足够的量定义为每次评估的总接种量≥1mL。对于首次评估,当地指南建议发送一组需氧-厌氧培养瓶,每个培养瓶接种 1mL。
在 788 名婴儿中进行了 987 次评估。临床医生报告 96.9%的评估中总接种量≥1mL。在 544 次对培养瓶称重的评估中,93.4%的评估总接种量≥1mL。出生后>7 天进行评估的极低出生体重儿接种物不足的比例最高(14.4%)。仅在 3/544 次评估和 26/1011 个瓶中总接种量<0.5mL。尽管总接种量允许在其中一个瓶中接种≥1mL,但仍有 90 次评估中两个瓶中的接种量均<1mL。
在大多数新生儿中获得推荐的接种量是可行的。测量接种量可以集中精力改进并提高检测可靠性。
临床医生对新生儿血培养的可靠性表示担忧,因为接种量不足。我们调查了 900 多次评估,发现>90%的评估中总接种量≥1mL。监测血培养技术的充分性可以确定需要改进的领域,并可能减轻对血培养可靠性的担忧。目前建议的新生儿血培养的足够接种量在大多数情况下得到满足。需要改进的领域包括早产儿晚发性败血症评估和接种期间的分配技术。